[
  {
    "title": "STAT+: NIH Director Bhattacharya to lead CDC after O’Neill’s exit",
    "link": "https://www.statnews.com/2026/02/18/cdc-acting-director-jay-bhattacharya/?utm_campaign=rss",
    "source": "STAT News",
    "category": "industry",
    "date": "2026-02-18T18:48:30.000Z",
    "summary": "He's the third leader of the public health agency since this summer."
  },
  {
    "title": "Upcoming meeting of federal vaccine panel may be postponed after HHS missed deadlines",
    "link": "https://www.statnews.com/2026/02/18/cdc-vaccines-acip-meeting-may-be-postponed/?utm_campaign=rss",
    "source": "STAT News",
    "category": "industry",
    "date": "2026-02-18T17:09:21.000Z",
    "summary": "Federal officials have missed the legal deadline to notify the public of an upcoming ACIP meeting, raising questions about whether the meeting will be postponed."
  },
  {
    "title": "STAT wins fourth Polk Award for reporting on impact of Trump on health",
    "link": "https://www.statnews.com/2026/02/18/stat-wins-polk-award-reporting-trump-science-fda/?utm_campaign=rss",
    "source": "STAT News",
    "category": "industry",
    "date": "2026-02-18T16:45:14.000Z",
    "summary": "STAT has won its fourth Polk Award in five years for documenting the Trump administration’s shakeup of the FDA, scientific research, and public health."
  },
  {
    "title": "Lilly to pay CSL $100M to license monoclonal antibody targeting IL-6",
    "link": "https://www.biopharmadive.com/news/lilly-deal-csl-100m-license-monoclonal-antibody-targeting-il-6/812455/",
    "source": "BioPharma Dive",
    "category": "industry",
    "date": "2026-02-18T16:15:18.000Z",
    "summary": "The Australian company will retain rights for an end-stage kidney disease indication currently being tested in a Phase 3 trial while Lilly explores other uses."
  },
  {
    "title": "STAT+: AI Prognosis: Who’s keeping tabs on how health insurers are using AI?",
    "link": "https://www.statnews.com/2026/02/18/health-insurers-using-artificial-intelligence-ai-prognosis/?utm_campaign=rss",
    "source": "STAT News",
    "category": "industry",
    "date": "2026-02-18T15:43:06.000Z",
    "summary": "In this edition, AI Prognosis talks to STAT's Casey Ross, a Pulitzer finalist laser-focused on health insurers' use of AI, and more."
  },
  {
    "title": "FDA accepts BMS protein degrader for review; Disc rare disease drug rejected",
    "link": "https://www.biopharmadive.com/news/disc-news-roundup-pharma-biotech/812351/",
    "source": "BioPharma Dive",
    "category": "industry",
    "date": "2026-02-18T15:35:17.000Z",
    "summary": "Cytokinetics’ heart disease drug secured European approval. Elsewhere, Teva and Sanofi reported longer-term data from an experimental therapy targeting ulcerative colitis and Crohn’s disease."
  },
  {
    "title": "An Alzheimer’s startup emerges with $175M in venture backing",
    "link": "https://www.biopharmadive.com/news/korsana-alzheimers-amyloid-beta-plaque-launch/812443/",
    "source": "BioPharma Dive",
    "category": "industry",
    "date": "2026-02-18T15:22:54.000Z",
    "summary": "Backed by Wellington, Sanofi Ventures and a division of J.P. Morgan, Korsana Therapeutics is studying a treatment originally developed by hub-and-spoke biotech Paragon Therapeutics."
  },
  {
    "title": "STAT+: Investors cheer Compass’ psilocybin data",
    "link": "https://www.statnews.com/2026/02/18/biotech-news-investors-celebrate-compass-psilocybin-data/?utm_campaign=rss",
    "source": "STAT News",
    "category": "industry",
    "date": "2026-02-18T15:01:52.000Z",
    "summary": "And other biotech news brought to you by The Readout"
  },
  {
    "title": "STAT+: Pharmalittle: We’re reading about an FDA reversal on a Moderna vaccine, the U.K. life sciences sector, and more",
    "link": "https://www.statnews.com/pharmalot/2026/02/18/fda-moderna-vaccines-hhs-kennedy/?utm_campaign=rss",
    "source": "STAT News",
    "category": "industry",
    "date": "2026-02-18T14:41:09.000Z",
    "summary": "The FDA reversed course and told Moderna it would review its application for a new flu vaccine, after refusing to do so earlier this month"
  },
  {
    "title": "Psychedelics stocks rise as Compass’ psilocybin drug heads to FDA",
    "link": "https://www.biopharmadive.com/news/psychedelics-stocks-rise-as-compass-psilocybin-drug-heads-to-fda/812441/",
    "source": "BioPharma Dive",
    "category": "industry",
    "date": "2026-02-18T14:25:25.000Z",
    "summary": "Shares of at least four other developers were up by mid-single digits to low-double digits at certain points on Tuesday."
  },
  {
    "title": "FDA reverses course on Moderna’s flu vaccine",
    "link": "https://www.biopharmadive.com/news/fda-reverses-course-review-moderna-approval-application-influenza-/812432/",
    "source": "BioPharma Dive",
    "category": "industry",
    "date": "2026-02-18T14:24:47.000Z",
    "summary": "Moderna said after a \"Type A\" meeting, the agency agreed to move forward and review its application for the mRNA-based shot."
  },
  {
    "title": "STAT+: The FDA’s Moderna pirouette is one more sign of chaos at the agency",
    "link": "https://www.statnews.com/2026/02/18/moderna-fda-reversal-vinay-prasad/?utm_campaign=rss",
    "source": "STAT News",
    "category": "industry",
    "date": "2026-02-18T14:00:45.000Z",
    "summary": "For drugmakers and vaccine developers, an FDA reversal on Moderna's flu vaccine is better than the alternative. But it is also another sign of agency chaos."
  },
  {
    "title": "Proposed $7.25B settlement to resolve weedkiller cancer lawsuits",
    "link": "https://www.statnews.com/2026/02/18/health-news-roundup-weedkiller-cancer-lawsuit/?utm_campaign=rss",
    "source": "STAT News",
    "category": "industry",
    "date": "2026-02-18T12:58:06.000Z",
    "summary": "And other health news from the Morning Rounds newsletter"
  },
  {
    "title": "STAT+: FDA reverses course, agrees to review Moderna’s flu vaccine",
    "link": "https://www.statnews.com/2026/02/18/fda-moderna-reverse-course-flu-vaccine/?utm_campaign=rss",
    "source": "STAT News",
    "category": "industry",
    "date": "2026-02-18T12:29:42.000Z",
    "summary": "The FDA reversed course and told Moderna it would review its application for a new flu vaccine, the company announced Wednesday."
  },
  {
    "title": "STAT+: Biotech startup raises $175 million to advance Alzheimer’s antibody therapy",
    "link": "https://www.statnews.com/2026/02/18/korsana-biosciences-alzheimers-brain-shuttles/?utm_campaign=rss",
    "source": "STAT News",
    "category": "industry",
    "date": "2026-02-18T11:00:00.000Z",
    "summary": "Is there room for more Alzheimer’s antibody therapies on the market? Korsana Biosciences' investors think so."
  },
  {
    "title": "Opinion: I was a Moderna exec when the Covid vaccine rolled out. That spirit of possibility is no more",
    "link": "https://www.statnews.com/2026/02/18/moderna-mrna-flu-vaccine-trust-regulatory-uncertainty/?utm_campaign=rss",
    "source": "STAT News",
    "category": "industry",
    "date": "2026-02-18T09:30:00.000Z",
    "summary": "“The pharmaceutical industry is not the enemy,” writes Richard Hughes IV, who was Moderna’s VP for public policy when the Covid vaccine rolled out."
  },
  {
    "title": "STAT+: As oncologists ponder how to integrate AI-powered cancer tools, products are hitting the market",
    "link": "https://www.statnews.com/2026/02/18/ai-powered-cancer-tools-new-digital-pathology-valar-labs/?utm_campaign=rss",
    "source": "STAT News",
    "category": "industry",
    "date": "2026-02-18T09:30:00.000Z",
    "summary": "Oncologists say there is promise in new AI tools that can guide them when choosing between two plausible treatments."
  },
  {
    "title": "Opinion: Same blood test, different results:  Why isn’t this common thyroid screening reliable?",
    "link": "https://www.statnews.com/2026/02/18/tsh-thyroid-stimulating-hormone-blood-test-pituitary-labs-standardized-assay/?utm_campaign=rss",
    "source": "STAT News",
    "category": "industry",
    "date": "2026-02-18T09:30:00.000Z",
    "summary": "Researchers have known for decades that different brands of lab machines produce different results. The fix is easy — but not enforced."
  },
  {
    "title": "PIP4K2C: an emerging fulcrum for multiple diseases",
    "link": "https://www.nature.com/articles/d41573-026-00030-8",
    "source": "Nature Reviews Drug Discovery",
    "category": "research",
    "date": "2026-02-18T00:00:00.000Z",
    "summary": ""
  },
  {
    "title": "STAT+: At drugmakers’ forum, Oz gets a friendly embrace, while Makary faces tough questions",
    "link": "https://www.statnews.com/2026/02/17/pharma-forum-highlights-industry-divide-oz-makary/?utm_campaign=rss",
    "source": "STAT News",
    "category": "industry",
    "date": "2026-02-17T23:28:45.000Z",
    "summary": "Two of health secretary Robert F. Kennedy Jr.’s top lieutenants struck decidedly different tones at a forum held Tuesday by the pharmaceutical industry group PhRMA."
  },
  {
    "title": "Bayer agrees to $7.25 billion proposed settlement over thousands of Roundup cancer lawsuits",
    "link": "https://www.statnews.com/2026/02/17/bayer-settlement-lawsuits-roundup-weedkiller-cancer/?utm_campaign=rss",
    "source": "STAT News",
    "category": "industry",
    "date": "2026-02-17T21:17:53.000Z",
    "summary": "Bayer has agreed to $7.25 billion proposed settlement over thousands of lawsuits alleging the company failed to warn people that its popular weedkiller Roundup could cause cancer."
  },
  {
    "title": "STAT+: A shakeup at HHS, a toast to bipartisanship, and a cheese poof war",
    "link": "https://www.statnews.com/2026/02/17/health-policy-news-who-is-leading-the-cdc/?utm_campaign=rss",
    "source": "STAT News",
    "category": "industry",
    "date": "2026-02-17T18:37:39.000Z",
    "summary": "You're reading the web edition of D.C. Diagnosis, STAT's guide to the ins and outs and oddities of health politics and policy"
  },
  {
    "title": "STAT+: The health care economy, and a surprising Humira chart",
    "link": "https://www.statnews.com/2026/02/17/health-care-inc-a-surprising-humira-chart-skyrizi/?utm_campaign=rss",
    "source": "STAT News",
    "category": "industry",
    "date": "2026-02-17T18:29:05.000Z",
    "summary": "This is the online version of the essential and fabulous Health Care Inc. newsletter"
  },
  {
    "title": "Compass, with Phase 3 hits, ready to take psilocybin to the FDA",
    "link": "https://www.biopharmadive.com/news/compass-trial-data-fda-application-psilocybin-psychedelics/812332/",
    "source": "BioPharma Dive",
    "category": "industry",
    "date": "2026-02-17T16:53:15.000Z",
    "summary": "The company plans to meet with the FDA to discuss a rolling approval application for “COMP360,” a synthetic form of psilocybin that could become the first “classic” psychedelic cleared for the U.S.…"
  },
  {
    "title": "Ocular claims a win with eye drug data even as shares sink",
    "link": "https://www.biopharmadive.com/news/ocular-therapeutix-succeeded-phase-3-eye-drug-data-axpaxli-eylea/812329/",
    "source": "BioPharma Dive",
    "category": "industry",
    "date": "2026-02-17T16:07:37.000Z",
    "summary": "Investors were looking for a greater difference between Ocular’s experimental medicine and a low-dose version of Eylea, analysts said."
  },
  {
    "title": "STAT+: Does Medicare’s ACCESS model pay enough?",
    "link": "https://www.statnews.com/2026/02/17/does-medicare-access-model-pay-enough-health-tech/?utm_campaign=rss",
    "source": "STAT News",
    "category": "industry",
    "date": "2026-02-17T15:31:50.000Z",
    "summary": "In this edition of STAT Health Tech: Payment rates for Medicare's ACCESS model, health insurers' use of AI, and more."
  },
  {
    "title": "STAT+: Psilocybin data could be good enough for approval",
    "link": "https://www.statnews.com/2026/02/17/biotech-news-compass-psilocybin-data-for-fda/?utm_campaign=rss",
    "source": "STAT News",
    "category": "industry",
    "date": "2026-02-17T14:57:05.000Z",
    "summary": "And other biotech news brought to you by The Readout newsletter"
  },
  {
    "title": "STAT+: Pharmalittle: We’re reading about China’s homegrown GLP-1 drugs, a puzzling FDA rejection, and more",
    "link": "https://www.statnews.com/pharmalot/2026/02/17/india-ireland-china-glp-lilly-novo-obesity-vaccines-peanuts-africa/?utm_campaign=rss",
    "source": "STAT News",
    "category": "industry",
    "date": "2026-02-17T14:21:26.000Z",
    "summary": "The FDA rejected a Disc Medicine therapy for a rare blood disorder, the first experimental drug to go through a new program to fast-track drug reviews"
  },
  {
    "title": "Selecting the optimal cell therapy manufacturing platform",
    "link": "https://www.biopharmadive.com/spons/selecting-the-optimal-cell-therapy-manufacturing-platform/812042/",
    "source": "BioPharma Dive",
    "category": "industry",
    "date": "2026-02-17T10:00:00.000Z",
    "summary": "Navigating modular vs. integrated platforms—find the best path for your cell therapy program."
  },
  {
    "title": "How to evaluate prospective diagnostic laboratory partners for your patient support program",
    "link": "https://www.biopharmadive.com/spons/how-to-evaluate-prospective-diagnostic-laboratory-partners-for-your-patient/810447/",
    "source": "BioPharma Dive",
    "category": "industry",
    "date": "2026-02-17T10:00:00.000Z",
    "summary": "As specialty medicines account for an increasing share of the drug pipeline, it makes sense for sponsors to support patients financially, emotionally and logistically."
  },
  {
    "title": "Therapeutic targeting of neuroimmune mechanisms in neurodegeneration",
    "link": "https://www.nature.com/articles/s41573-025-01370-7",
    "source": "Nature Reviews Drug Discovery",
    "category": "research",
    "date": "2026-02-16T00:00:00.000Z",
    "summary": ""
  },
  {
    "title": "TIGIT’s immuno-oncology teachings",
    "link": "https://www.nature.com/articles/d41573-026-00031-7",
    "source": "Nature Reviews Drug Discovery",
    "category": "research",
    "date": "2026-02-16T00:00:00.000Z",
    "summary": ""
  },
  {
    "title": "Vertex’s CRISPR therapy rebounds in latest earnings",
    "link": "https://www.biopharmadive.com/news/vertex-earnings-casgevy-q4-2025/812243/",
    "source": "BioPharma Dive",
    "category": "industry",
    "date": "2026-02-13T18:00:21.000Z",
    "summary": "Sales of Casgevy, a gene-edited treatment developed with CRISPR Therapeutics, more than tripled compared to the third quarter, a performance analysts saw as a bright spot in Vertex's report."
  },
  {
    "title": "Approvals by the China NMPA in 2025",
    "link": "https://www.nature.com/articles/d41573-026-00028-2",
    "source": "Nature Reviews Drug Discovery",
    "category": "research",
    "date": "2026-02-13T00:00:00.000Z",
    "summary": ""
  },
  {
    "title": "FDA Approves Labeling Changes to Menopausal Hormone Therapy Products",
    "link": "http://www.fda.gov/news-events/press-announcements/fda-approves-labeling-changes-menopausal-hormone-therapy-products",
    "source": "FDA Press Releases",
    "category": "regulatory",
    "date": "2026-02-12T16:17:42.000Z",
    "summary": "The U.S. Food and Drug Administration has approved drug labeling changes to six menopausal hormone therapy products, also known as hormone replacement therapy (HRT), to clarify risk considerations…"
  },
  {
    "title": "FDA Approves First-of-Its-Kind Device to Treat Pancreatic Cancer",
    "link": "http://www.fda.gov/news-events/press-announcements/fda-approves-first-its-kind-device-treat-pancreatic-cancer",
    "source": "FDA Press Releases",
    "category": "regulatory",
    "date": "2026-02-12T13:33:59.000Z",
    "summary": "The U.S. Food and Drug Administration has approved a first-of-its-kind device for the treatment of adult patients with locally advanced pancreatic cancer."
  }
]
